Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Akriderm
- Development stage
- Unknown
- Lead developer
- Akrikhin
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Akriderm is a topical corticosteroid containing betamethasone dipropionate, developed and manufactured by the Russian pharmaceutical company Akrikhin. It is primarily indicated for the treatment of inflammatory and allergic skin conditions, including various forms of dermatitis, eczema, and psoriasis. As a synthetic glucocorticoid, it exerts potent anti-inflammatory, antipruritic, and vasoconstrictive effects by binding to intracellular glucocorticoid receptors, thereby modulating gene expression to reduce the production of inflammatory mediators. The product line also includes combination formulations such as Akriderm Genta (with gentamicin), Akriderm GK (with gentamicin and clotrimazole), and Akriderm SK (with salicylic acid).
- Brand names
- Akriderm
- Other names
- betamethasone dipropionate
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on Akriderm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akriderm.